The importance of appropriate initial antibiotic therapy for hospital-acquired infections

American Journal of Medicine

Volumn 115, Issue 7, 2003, Pages 582-584

  Kollef, Marin H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CANDIDA; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOXICITY; EDITORIAL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA; MORBIDITY; MORTALITY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS;

EID: 0242361304     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.09.002     Document Type: Editorial

References (12)

1. Neuhauser M.M., Weinstein R.A., Rydman R., et al. Antibiotic resistance among gram-negative bacilli in US intensive care units implications for fluoroquinolone use . JAMA. 289:2003;885-888.
2. Richards M.J., Edwards J.R., Culver D.H., et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 27:1999;887-892.
3. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep. 51:2002;565-566.
4. Garnacho-Montero J., Ortiz-Leyba C., Jimenez-Jimenez F.J., et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin a comparison with imipenem- susceptible VAP . Clin Infect Dis. 36:2003;1111-1118.
5. Kollef M.H. Inadequate antimicrobial treatment an important determinant of outcome for hospitalized patients . Clin Infect Dis. 31:(suppl):2000;S131- S138.
6. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest. 115:1999;462-474.
7. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 118:2000;146-155.
8. Lodise T.P., McKinnon P.S., Swiderski L., et al. Outcome analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 36:2003;1418-1423.
9. Garnacho-Montero, J Garcia-Garmendia, JL Barrero-Almodovar, AE, et al. Impact of the outcome of adequate empirical antibiotherapy in patients admitted to the ICU for sepsis. Crit Care Med. 2003;volume:000-000.
10. Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 115:2003;529-535.
11. Ibrahim E.H., Ward S., Sherman G., et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 29:2001;1109-1115.
12. Rello J., Sa-Borges M., Correa H., et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites implications for antimicrobial prescribing practices . Am J Respir Crit Care Med. 160:1999;608-613.